Recombinant Human SLC25A19 Protein，His

SLC25A19, a member of the solute carrier family, encodes a mitochondrial protein primarily involved in the transport of key metabolites across the mitochondrial membrane. Its dysfunction has been linked to a rare genetic disorder known as B phosphate transport defect (BPTD), which is characterized by neurological impairments and metabolic dysregulation. Recent studies have shown that mutations in the SLC25A19 gene lead to disruptions in mitochondrial function and energy metabolism, underscoring the importance of this protein in cellular homeostasis. Research into the recombinant form of SLC25A19 aims to elucidate its structure-function relationship and the mechanisms by which it facilitates mitochondrial transport. Producing recombinant SLC25A19 protein offers the potential to investigate its biophysical properties, interaction with other mitochondrial proteins, and the effects of specific mutations. Understanding the functional implications of SLC25A19 is crucial for developing targeted therapies for disorders associated with its dysfunction. As mitochondrial dysfunction is implicated in a range of diseases, including neurodegenerative disorders and metabolic syndromes, insights gained from studying SLC25A19 could have far-reaching implications in both basic biology and clinical applications. Thus, the exploration of SLC25A19 through recombinant protein studies represents a significant advance in our understanding of mitochondrial transport mechanisms and their impact on human health.